About 1 result found for searched term "Onvansertib" (0.148 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M13718 | Onvansertib | PLK |
| PCM-075; NMS-1286937; NMS-P937 | ||
| Onvansertib (PCM-075, NMS-1286937, NMS-P937) is a first-in-class, third-generation, oral, highly selective PLK1 inhibitor that induces tumor cell arrest in the G2/M phase and triggers apoptosis. It has a median IC50=136nM against a variety of CRC cell lines and inhibits xenograft models such as HT-29, HCT-116, and Colo-205 well. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
